Milena Engelke

Ms. Milena Engelke

Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Bavaria, Germany
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
SMSteven Marcrum
Steven Marcrum
MEMilena Engelke
Milena Engelke
HGHazel Goedhart
Hazel Goedhart
BLBerthold Langguth
Berthold Langguth
Winfried SchleeWinfried Schlee
Winfried Schlee
Jorge Piano SimõesJorge Piano Simões
Jorge Piano Simões
Optimization of dietary intake is an essential component in the multidimensional effort to prevent and manage chronic disease. Recently, demand has increased for nutrition-focused management strategies for chronic tinnitus. The primary aim of this study was to evaluate 10 dietary items for their association with changes in subjective tinnitus severity. A secondary aim was to develop an algorithm to better identify those individuals who might benefit from dietary modification strategies. A total of 5017 anonymous users of the TinnitusTalk forum completed an online survey regarding how various dietary items affected the severity of their tinnitus. Results suggest that, while intake of caffeine [positive effect (PE): 0.4%; negative effect (NE): 16.2%], alcohol (PE: 2.7%; NE: 13.3%, and salt (PE: 0.1%; NE: 9.9%) was most likely to influence tinnitus severity, it did so only for a small proportion of participants and reported effects were most commonly mild. Further, though a classification algorithm was able to leverage participant demographic, comorbidity, and tinnitus characteristics to identify those individuals most likely to benefit from dietary modification above chance levels, further efforts are required to achieve significant clinical utility. Taken together, these results do not support dietary modification as a primary treatment strategy for chronic tinnitus in the general population, though clinically meaningful effects might be observable in certain individuals.

20 March 2025 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Open access
MEMilena Engelke
Milena Engelke
LBLaura Basso
Laura Basso
BLBerthold Langguth
Berthold Langguth
FZFlorian Zeman
Florian Zeman
WSWinfried Schlee
Winfried Schlee
JSJorge Piano Simões
Jorge Piano Simões
Objective: The minimal clinically important difference (MCID) represents the smallest change in treatment outcome deemed clinically meaningful. This study estimates the MCID for 2 widely used tinnitus measures: the Tinnitus Handicap Inventory (THI) and the Tinnitus Functional Index (TFI), using anchor‐based approaches while accounting for baseline severity and time interval.Study Design: A multi‐center randomized clinical trial.Setting: European tinnitus centers.Methods: Anchor‐based approaches, including the effect size, receiver‐operating characteristics, and ΔTHI/TFI methods, were employed to determine the MCID. The “minimally improved” category of the Clinical Global Impression Scale‐Improvement (CGI‐I) served as the anchor. The standard error of measurement was used to assess random variation.Results: For the THI, MCID estimates ranged from 7.8 to 12, with a point estimate of 11 after 12 weeks of treatment (N = 364). For the TFI, MCID estimates ranged from 7.3 to 9.4, with a point estimate of 9 points after 12 weeks (N = 359). Both measures indicated that higher baseline severity and longer time intervals required greater score reduction for clinical relevance.Conclusion: This study highlights the context‐specific nature of MCID values for tinnitus measures and emphasizes the need for consensus on optimal anchor‐based approaches to improve comparability.

18 January 2023 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
MEMilena Engelke
Milena Engelke
JSJorge Simões
Jorge Simões
CVCarsten Vogel
Carsten Vogel
SSStefan Schoisswohl
Stefan Schoisswohl
MSMartin Schecklmann
Martin Schecklmann
WSWinfried Schlee
Winfried Schlee
Tinnitus affects a considerable part of the population and develops into a severe disorder in some sufferers. App-based interventions are able to provide low-threshold, cost-effective, and location-independent care for tinnitus patients. Therefore, we developed a smartphone app combining structured counseling with sound therapy and conducted a pilot study to evaluate treatment compliance and symptom improvement (trial registration: DRKS00030007). Outcome variables were Ecological Momentary Assessment (EMA) measured tinnitus distress and loudness and Tinnitus Handicap Inventory (THI) at baseline and final visit. A multiple-baseline design with a baseline phase (only EMA) followed by an intervention phase (EMA and intervention) was applied. 21 patients with chronic tinnitus (≥ 6 months) were included. Overall compliance differed between modules (EMA usage: 79% of days, structured counseling: 72%, sound therapy: 32%). The THI score improved from baseline to final visit indicating a large effect (Cohens d = 1.1). Tinnitus distress and loudness did not improve significantly from baseline phase to the end of intervention phase. However, 5 of 14 (36%) improved clinically meaningful in tinnitus distress (ΔDistress ≥ 10) and 13 of 18 (72%) in THI score (ΔTHI ≥ 7). The positive relationship between tinnitus distress and loudness weakened over the course of the study. A trend but no level effect for tinnitus distress could be demonstrated by a mixed effect model. The improvement in THI was strongly associated with the improvement scores in EMA of tinnitus distress (r = -0.75; 0.86). These results indicate that app-based structured counseling combined with sound therapy is feasible, has an impact on tinnitus symptoms and reduces distress for several patients. In addition, our data suggest that EMA could be used as a measurement tool to detect changes in tinnitus symptoms in clinical trials as has already been shown in other areas of mental health research.

14 January 2025 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
MEMilena Engelke
Milena Engelke
Jorge Piano SimõesJorge Piano Simões
Jorge Piano Simões
LBLaura Basso
Laura Basso
NWNina Wunder
Nina Wunder
BLBerthold Langguth
Berthold Langguth
Winfried SchleeWinfried Schlee
Winfried Schlee
Intensive longitudinal sampling enhances subjective data collection by capturing real-time, dynamic inputs in natural settings, complementing traditional methods. This study evaluates the feasibility of using daily self-reported app data to assess clinical improvement among tinnitus patients undergoing treatment. App data from a multi-center randomized clinical trial were analysed using time-series feature extraction and nested cross-validated ordinal regression with elastic net regulation to predict clinical improvement based on the Clinical Global Impression—Improvement scale (CGI-I). With 50% app compliance (N = 129, 8480 entries), the model demonstrated good fit to the test data (McFadden R2 = 0.82) suggesting its generalizability. Clinical improvement was associated with linear declines in tinnitus-related thoughts, jaw tension, tinnitus loudness, increases in happiness, and variability changes in tinnitus loudness and distress. These findings suggest that daily self-reported data on tinnitus symptoms is sensitive to treatment response and provides insights into specific symptom changes that occur during treatment.

9 June 2025 in Journal of the Association for Research in Otolaryngology
Verified
Journal Article
Open access
PDF file
MEMilena Engelke
Milena Engelke
SMSebastian Müller
Sebastian Müller
BLBerthold Langguth
Berthold Langguth
RPRüdiger Pryss
Rüdiger Pryss
WSWinfried Schlee
Winfried Schlee
Tinnitus, a common auditory phenomenon, often presents with considerable between-person heterogeneity and within-person fluctuations. To understand the pathophysiological mechanisms and advance patient-centred care, it is essential to recognise these variations. Ecological Momentary Assessment (EMA) is a (close-to) real-time data collection method that offers insights into short- and long-term fluctuations of subjective symptoms and their interaction with psychological, environmental, and physiological factors. EMA applied in tinnitus research has shown promise in capturing the nuances of tinnitus experience in naturalistic settings, minimizing recall bias inherent in traditional retrospective methods. This narrative literature review aims to provide a comprehensive up-to-date picture of EMA in tinnitus research by describing previous and current applications, summarising scientific findings, and identifying research gaps by drawing lessons from adjacent mental health fields. 28 publications were identified and assigned to six different topics based on thematic and methodological matters. We highlight contributions of EMA methodology for tinnitus research such as findings on momentary and longitudinal symptom interactions, circadian rhythms, individual differences in symptom patterns and its contributions to treatment evaluation. Emerging technologies, including machine learning, are opening new avenues for personalised tinnitus understanding and management. Despite promising advances, challenges such as data reliability, participant compliance, and integration with sensor-based passive data collection remain areas for further exploration. Drawing lessons from adjacent mental health fields, we propose future directions for EMA in tinnitus research, emphasizing the integration of multimodal data, advanced analytics, and ecological validity to enhance the understanding and management of chronic tinnitus.

9 January 2024 in medRxiv
Verified
Preprint
Open access
PDF file
SSStefan Schoisswohl
Stefan Schoisswohl
LBLaura Basso
Laura Basso
JSJorge Simoes
Jorge Simoes
MEMilena Engelke
Milena Engelke
BLBerthold Langguth
Berthold Langguth
Winfried SchleeWinfried Schlee
Winfried Schlee
Tinnitus is associated with a variety of aetiologies, phenotypes, and underlying pathophysiological mechanisms, and available treatments have limited efficacy. A combination of treatments, addressing various aspects of tinnitus, might provide a viable and superior treatment strategy. In this international multicentre, parallel-arm, superiority, randomised controlled trial, patients with chronic subjective tinnitus were recruited from five clinical sites across the EU as part of the interdisciplinary collaborative UNITI project. Patients were randomly assigned using a web-based system, stratified by their hearing and distress level, to single or combination treatment of 12 weeks. Cognitive-behavioural therapy, hearing aids, structured counselling, and sound therapy were administered either alone or as a combination of two treatments resulting in ten treatment arms. The primary outcome was the difference in the change from baseline to week 12 in the total score of the Tinnitus Handicap Inventory (THI) between single and combination treatments in the intention-to-treat population. All statistical analysis were performed blinded to treatment allocation. 674 patients of both sexes aged between 18 and 80 years were screened for eligibility. 461 participants (190 females) with chronic subjective tinnitus and at least mild tinnitus handicap were enrolled, 230 of which were randomly assigned to single and 231 to combination treatment. Least-squares mean changes from baseline to week 12 were -11.7 for single treatment (95% confidence interval [CI], -14.4 to -9.0) and -14.9 for combination treatments (95% CI, -17.7 to -12.1), with a statistically significant group difference ( p =0.034). Cognitive-behavioural therapy and hearing aids alone had large effect sizes, which could not be further increased by combination treatment. No serious adverse events occurred. In this trial involving patients with chronic tinnitus, all treatment arms showed improvement in THI scores from baseline to week 12. Combination treatments showed a stronger clinical effect than single treatment, however, no clear synergistic effect was observed when combining treatments. We observed rather a compensatory effect, where a more effective treatment offsets the clinical effects of a less effective treatment. ClinicalTrials.gov Identifier: NCT04663828 .